Fig. 6From: Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer a Correlation between L/B ratio measured on malignant and benign lesions from 99mTc sestamibi and 99mTc maraciclatide images (malignant, r = 0.82; benign, r = 0.96; all lesions, r = 0.87). b Correlation between L/B ratio in malignant and benign lesions from 99mTc sestamibi and 99mTc maraciclatide images measured using the 1-day and 2-day protocols (1-day protocol, r = 0.89, solid line; 2-day protocol, r = 0.85, dotted line)Back to article page